Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat and SOCS box protein 11 (ASB11) is a member of the ankyrin repeat and SOCS box family that acts as a substrate-recognition subunit within Elongin–Cullin–SOCS (ECS) E3 ubiquitin ligase complexes. ASB11 localizes to the endoplasmic reticulum and mediates the ubiquitination—and subsequent proteasomal degradation—of select proteins such as Ribophorin 1 (an integral part of the OST glycosylation complex). ASB11 also targets pro-apoptotic proteins such as BIK for degradation, regulating cell survival in response to ER stress and the unfolded protein response. Functionally, ASB11 is crucial for maintenance of cell progenitor compartments (notably in neural and muscle tissues) and inhibits terminal cell differentiation, likely through activation of Notch signaling. This makes ASB11 a key molecular gatekeeper of compartment size and regeneration in vertebrate tissues.
E3 ligase-mediated ubiquitination of substrate proteins (for instance, Ribophorin 1 and BIK), leading to their proteasomal degradation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat and SOCS box protein 11 (ASB11).